On December 28, 2020, the National Healthcare Security Administration and the Ministry of Human Resources and Social Security issued a notice on the Release of the List of Drugs for National Basic Medical Insurance, Occupational Injury Insurance and Maternity Insurance (2020 Edition)（click to view）
Warm congratulations on Reflow™'s entry into the National Drug Reimbursement List!
The thrombolysis patency rate of Reflow is as high as 83%.
It only takes 5-10 seconds for a single injection to realize thrombolysis.
It brings more effective and timely treatment to patients with acute myocardial infarction (AMI).